Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Power Life Sciences Inc.500 enrolled

Overview

Historically, clinical study participation has been biased toward certain demographics. However, there is a shortage of studies that delve into the underlying factors that influence patient participation, both positively and negatively. Several people will be invited to enroll in this study so that it may collect a variety of data about glioblastoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. The data collected from this study will be analyzed and used to improve the experiences of future glioblastoma patients who are recruited for medical trials.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Glioblastoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has self-identified as planning to enroll in a clinical trial * Patient has been diagnosed with glioblastoma * Patient is a minimum of 18 years or older Exclusion Criteria: * Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant

Outcomes

Primary Outcomes

Number of patients who decide to participate in a glioblastoma clinical trial

Time frame: 3 months

Rate of patients who remain in glioblastoma clinical trial to trial completion